- Home
- CODX vs COCP Comparison
CODX vs COCP Comparison
Compare CODX & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODX
- COCP
- Stock Information
- Founded
- CODX 2013
- COCP 2006
- Country
- CODX United States
- COCP United States
- Employees
- CODX N/A
- COCP N/A
- Industry
- CODX Medical/Dental Instruments
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- CODX Health Care
- COCP Health Care
- Exchange
- CODX Nasdaq
- COCP Nasdaq
- Market Cap
- CODX 15.6M
- COCP 15.4M
- IPO Year
- CODX 2017
- COCP N/A
- Fundamental
- Price
- CODX $0.40
- COCP $1.09
- Analyst Decision
- CODX Buy
- COCP Strong Buy
- Analyst Count
- CODX 2
- COCP 1
- Target Price
- CODX $2.00
- COCP $6.00
- AVG Volume (30 Days)
- CODX 60.4M
- COCP 221.4K
- Earning Date
- CODX 11-13-2025
- COCP 11-14-2025
- Dividend Yield
- CODX N/A
- COCP N/A
- EPS Growth
- CODX N/A
- COCP N/A
- EPS
- CODX N/A
- COCP N/A
- Revenue
- CODX $1,003,653.00
- COCP N/A
- Revenue This Year
- CODX N/A
- COCP N/A
- Revenue Next Year
- CODX $31.58
- COCP N/A
- P/E Ratio
- CODX N/A
- COCP N/A
- Revenue Growth
- CODX N/A
- COCP N/A
- 52 Week Low
- CODX $0.23
- COCP $1.01
- 52 Week High
- CODX $1.55
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- CODX 48.90
- COCP 41.43
- Support Level
- CODX $0.43
- COCP $1.06
- Resistance Level
- CODX $0.51
- COCP $1.15
- Average True Range (ATR)
- CODX 0.14
- COCP 0.07
- MACD
- CODX -0.00
- COCP 0.01
- Stochastic Oscillator
- CODX 8.06
- COCP 24.60
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).